G-Cox 120 Tablet

About G-Cox 120 Tablet

G-Cox 120 is a tablet medicine containing etoricoxib 120 mg. It is a non-steroidal anti-inflammatory drug used for short-term relief of the pain and inflammation of acute gouty arthritis, as directed by a doctor.

There are 90 brands of Etoricoxib listed in Bangladesh. The lowest listed price is Retoz 90 mg Tablet at ৳ 1 per unit.

What is G-Cox 120 Tablet?

G-Cox 120 is a tablet from G. A. Company Ltd. containing etoricoxib 120 mg. Etoricoxib belongs to the group of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, which work against the prostanoids that drive pain, inflammation and fever. It is prescribed for the pain and signs of inflammation of acute gouty arthritis, given for a short course. It is also used in some other joint and pain conditions. Whether it is suitable for you depends on your health and other medicines, so the doctor decides.

Uses of G-Cox 120

G-Cox 120 is used to relieve the pain and inflammation linked with acute gouty arthritis, on a short-term basis. Etoricoxib is also prescribed for other painful joint conditions and for short-term moderate pain after dental surgery, but only when a doctor has decided it is appropriate. Ask your doctor what your course is for and how long it should last.

How to use G-Cox 120

Take G-Cox 120 exactly as your doctor tells you. The tablet is usually swallowed whole with water, and you can ask your pharmacist whether it should be taken with food. Do not change the amount or stop early on your own. The doctor decides the dose and the length of the course, so follow the prescription and ask about anything that is unclear.

Side effects of G-Cox 120

Some people notice palpitations, tiredness, flu-like symptoms or easy bruising. Less common effects include dry mouth, taste changes, mouth ulcers, appetite or weight changes, chest pain, flushing, cough, breathlessness, nosebleeds, anxiety, reduced mental alertness, tingling, electrolyte changes, and muscle or joint pain. Very rarely, confusion and hallucinations have been reported. Tell your doctor if any effect troubles you.

Safety and precautions

Do not use G-Cox 120 if you are pregnant or breastfeeding, or if you are trying to conceive, and tell your doctor if any of these apply. It should be avoided in people with an active ulcer or stomach bleeding, severe liver or kidney problems, heart failure, inflammatory bowel disease, or a history of allergic reactions to aspirin or NSAIDs. Older people and those with stomach, heart or kidney risk factors need extra care, so speak to your doctor before starting.

Frequently asked questions

How should I store G-Cox 120?

Keep the tablets at a temperature below 30°C, away from light and moisture. Store them in the original pack and out of the reach of children. Do not use tablets that look damaged or have passed their expiry date, and ask your pharmacist if you are unsure how to dispose of them.

What is G-Cox 120 used for and what kind of medicine is it?

It is a tablet containing etoricoxib 120 mg, a non-steroidal anti-inflammatory drug of the COX-2 inhibitor type. It is used for short-term relief of the pain and inflammation of acute gouty arthritis and some other painful conditions. Your doctor will explain what it is prescribed for in your case.

Is G-Cox 120 safe during pregnancy or breastfeeding?

It should not be used during pregnancy or while breastfeeding. It is also not recommended for women who are trying to conceive. If you are pregnant, think you may be, or are breastfeeding, tell your doctor before taking it so that another option can be considered.

Can I take G-Cox 120 with other medicines?

Some medicines can interact with it, including blood thinners such as warfarin, diuretics, ACE inhibitors, angiotensin II antagonists, ciclosporin and tacrolimus. Give your doctor and pharmacist a full list of everything you take, and do not add any medicine, including painkillers, without asking first.

Indications

Etoricoxib is indicated for the symptomatic relief of-
  • Osteoarthritis (OA)
  • Rheumatoid arthritis (RA)
  • Ankylosing spondylitis, and
  • The pain and signs of inflammation associated with acute gouty arthritis.
  • For the short-term treatment of moderate pain associated with dental surgery.

Pharmacology

Etoricoxib is a potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor within, and significantly above, the clinical dose range. Two isoforms of cyclooxygenase have been identified: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 is responsible for prostaglandin-mediated normal physiologic functions such as gastric cytoprotection and platelet aggregation. Inhibition of COX-1 by nonselective NSAIDs has been associated with gastric damage and inhibition of platelet aggregation. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Selective inhibition of COX-2 by etoricoxib (within the clinical dose range) decreases these clinical signs and symptoms with decreased potential for Gl toxicity and effects on platelet aggregation. Etoricoxib produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily. Etoricoxib did not inhibit gastric prostaglandin synthesis.

Dosage & Administration

Adult and adolescent over 16 years:
  • Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
  • Rheumatoid arthritis: The recommended dose is 90 mg once daily.
  • Ankylosing spondylitis: The recommended dose is 90 mg once daily.
  • Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
  • Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
Some patients may require additional postoperative analgesia. As the cardiovascular risks of Etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis.

Interaction

With medicine:
  • Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
  • Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
  • Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
  • Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
  • Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
With food & others: Take without regards to meals.

Contraindications

  • Hypersensitivity to the active substance or to any of the excipients.
  • Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
  • Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
  • Pregnancy and lactation.
  • Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
  • Estimated renal creatinine clearance <30 ml/min.
  • Children and adolescents under 16 years of age.
  • Inflammatory bowel disease.
  • Congestive heart failure (NYHA ll-IV).
  • Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
  • Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.

Side Effects

Side-effects may include palpitation, fatigue, influenza-like symptoms, ecchymosis; less commonly dry mouth, taste disturbance, mouth ulcer, appetite and weight change, atrial fibrillation, transient ischaemic attack, chest pain, flushing, cough, dyspnoea, epistaxis, anxiety, mental acuity impaired, paraesthesia, electrolyte disturbance, myalgia and arthralgia; very rarely confusion and hallucinations.

Pregnancy & Lactation

The use of Etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. It is not known whether Etoricoxib is excreted in human milk. Etoricoxib is excreted in the milk of lactating rats. Women who use Etoricoxib must not breastfeed.

Precautions & Warnings

  • Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
  • Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
  • Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
  • Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
  • Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
  • Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
  • Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.

Overdose Effects

Administration of single doses of Etoricoxib up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. In the event of overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the Gl tract, employ clinical monitoring, and institute supportive therapy, if required.

Storage Conditions

Store at a temperature of below 30°C, protect from light & moisture. Keep out of reach of children.

Alternative brands of Etoricoxib

Other brands with the same generic name, cheapest first.

Eto Tablet

60 mg

Etoricoxib

Delta Pharma Limited

৳ 7.00 per unit

Rito Tablet

60 mg

Etoricoxib

Opsonin Pharma Limited

৳ 7.03 per unit

Coxia Tablet

60 mg

Etoricoxib

Advanced Chemical Industries PLC

৳ 7.05 per unit

See all 90 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.